Danaher CapEx decreased by 36.1% to $237.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.3%, from $245.00M to $237.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -1.7% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $305.00M | $318.00M | $366.00M | $250.00M | $296.00M | $277.00M | $295.00M | $266.00M | $329.00M | $354.00M | $434.00M | $291.00M | $287.00M | $298.00M | $516.00M | $245.00M | $248.00M | $292.00M | $371.00M | $237.00M |
| QoQ Change | — | +4.3% | +15.1% | -31.7% | +18.4% | -6.4% | +6.5% | -9.8% | +23.7% | +7.6% | +22.6% | -32.9% | -1.4% | +3.8% | +73.2% | -52.5% | +1.2% | +17.7% | +27.1% | -36.1% |
| YoY Change | — | — | — | — | -3.0% | -12.9% | -19.4% | +6.4% | +11.1% | +27.8% | +47.1% | +9.4% | -12.8% | -15.8% | +18.9% | -15.8% | -13.6% | -2.0% | -28.1% | -3.3% |